Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.

Autor: Xie X; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Current Institution: Cancer Biology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA., Chauhan GB; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Edupuganti R; Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas., Kogawa T; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Park J; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tacam M; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tan AW; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mughees M; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vidhu F; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liu DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Taliaferro JM; Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas., Pitner MK; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Browning LS; Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas., Lee JH; Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas., Shen Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ueno NT; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Current Institution: Cancer Biology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA., Krishnamurthy S; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Van Laere SJ; Center for Oncological Research, Integrated Personalized and Precision Oncology Network, University of Antwerp, Antwerp, Wilrijk.; Department Oncology, KU Leuven, Leuven, Belgium., Bartholomeusz G; Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dalby KN; Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas., Bartholomeusz C; Section of Translational Breast Cancer Research, Houston, Texas.; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer research communications [Cancer Res Commun] 2023 Jun 20; Vol. 3 (6), pp. 1078-1092. Date of Electronic Publication: 2023 Jun 20 (Print Publication: 2023).